Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 3 6Phase 1/2 5Phase 1 4Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 2Orbital lymphoma 1Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 21Cyclosporine 14fludarabine phosphate 13Whole-Body Irradiation 13Peripheral Blood Stem Cell Transplantation 13Filgrastim 10Rituximab 9Mycophenolic Acid 9Antilymphocyte Serum 9Radiotherapy 7Methotrexate 7Busulfan 7Melphalan 6Psychiatric Rehabilitation 5Etoposide 5Dexamethasone 5Cytarabine 5Aprepitant 5fludarabine 4Vincristine 4Ondansetron 4Methylprednisolone 4Granulocyte Colony-Stimulating Factor 4Doxorubicin 4Cord Blood Stem Cell Transplantation 4plerixafor 3Zidovudine 3Therapeutics 3Stem Cell Transplantation 3Prednisone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Non-Hodgkin × ibritumomab tiuxetan × Clear all
NCT00387023 2013-11-18

Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma

M.D. Anderson Cancer Center

Phase NA Completed
12 enrolled 3 charts
Lymphoid

Orbital lymphoma, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡